StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note published on Wednesday. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of NYSE CO opened at $1.50 on Wednesday. The company has a market cap of $182.33 million, a P/E ratio of 2.34 and a beta of 0.16. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The firm has a 50-day simple moving average of $1.44 and a two-hundred day simple moving average of $1.35.
About Global Cord Blood
Featured Stories
- Five stocks we like better than Global Cord Blood
- ETF Screener: Uses and Step-by-Step Guide
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- What Are Growth Stocks and Investing in Them
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.